Craft
  • Home
  •  / Labcorp Drug Development
Labcorp Drug Development

Labcorp Drug Development

Revenue

$5.8 B

FY, 2021

Labcorp Drug Development Summary

Company summary

Overview
Labcorp Drug Development (formerly known as Covance) is a contract research and drug development company. It offers laboratory testing services to the chemical and agrochemical industries. The company also provides toxicology, central laboratory, discovery, and Phase III clinical trial management services.
Type
Subsidiary
Status
Active
Founded
1968
HQ
Princeton, NJ, US | view all locations
Website
https://drugdevelopment.labcorp.com/
Cybersecurity rating
Sectors

Key people

  • Paul Kirchgraber

    Paul Kirchgraber, Chief Executive Officer

  • William Hanlon

    William Hanlon, Chief Scientific Officer and President of Clinical Development & Commercialization Services, Clinical Therapy

  • Oren Cohen

    Oren Cohen, Chief Medical Officer and President, Clinical Pharmacology Services

  • Jill McConnell

    Jill McConnell, Chief Financial Officer

Operating MetricsView all

Trademarks (US)

24
9.1%

Nov, 2020

Patents

9

Nov, 2020

Services Provided

13

Nov, 2020

LocationsView all

79 locations detected

  • Princeton, NJ HQ

    United States

    206 Carnegie Center Dr

  • Ann Arbor, MI

    United States

    800 Technology Dr

  • Brentwood, TN

    United States

    201 Summit View Dr #200

  • Chantilly, VA

    United States

    3635 Concorde Pkwy #100

  • Dallas, TX

    United States

    1341 W Mockingbird Ln #200

  • Daytona Beach, FL

    United States

    1900 Mason Ave #140

and 73 others

Labcorp Drug Development Financials

Summary financials

Revenue (Q2, 2022)
$1.5B
EBIT (Q2, 2022)
$150.9M

Footer menu